356 related articles for article (PubMed ID: 15340146)
1. Exploring the O-GlcNAc proteome: direct identification of O-GlcNAc-modified proteins from the brain.
Khidekel N; Ficarro SB; Peters EC; Hsieh-Wilson LC
Proc Natl Acad Sci U S A; 2004 Sep; 101(36):13132-7. PubMed ID: 15340146
[TBL] [Abstract][Full Text] [Related]
2. Probing the dynamics of O-GlcNAc glycosylation in the brain using quantitative proteomics.
Khidekel N; Ficarro SB; Clark PM; Bryan MC; Swaney DL; Rexach JE; Sun YE; Coon JJ; Peters EC; Hsieh-Wilson LC
Nat Chem Biol; 2007 Jun; 3(6):339-48. PubMed ID: 17496889
[TBL] [Abstract][Full Text] [Related]
3. Cytosolic O-glycosylation is abundant in nerve terminals.
Cole RN; Hart GW
J Neurochem; 2001 Dec; 79(5):1080-9. PubMed ID: 11739622
[TBL] [Abstract][Full Text] [Related]
4. Deciphering the Functions of O-GlcNAc Glycosylation in the Brain: The Role of Site-Specific Quantitative O-GlcNAcomics.
Thompson JW; Sorum AW; Hsieh-Wilson LC
Biochemistry; 2018 Jul; 57(27):4010-4018. PubMed ID: 29936833
[TBL] [Abstract][Full Text] [Related]
5. A chemoenzymatic approach toward the rapid and sensitive detection of O-GlcNAc posttranslational modifications.
Khidekel N; Arndt S; Lamarre-Vincent N; Lippert A; Poulin-Kerstien KG; Ramakrishnan B; Qasba PK; Hsieh-Wilson LC
J Am Chem Soc; 2003 Dec; 125(52):16162-3. PubMed ID: 14692737
[TBL] [Abstract][Full Text] [Related]
6. A novel post-translational modification in nerve terminals: O-linked N-acetylglucosamine phosphorylation.
Graham ME; Thaysen-Andersen M; Bache N; Craft GE; Larsen MR; Packer NH; Robinson PJ
J Proteome Res; 2011 Jun; 10(6):2725-33. PubMed ID: 21500857
[TBL] [Abstract][Full Text] [Related]
7. Tools for probing and perturbing O-GlcNAc in cells and in vivo.
Cecioni S; Vocadlo DJ
Curr Opin Chem Biol; 2013 Oct; 17(5):719-28. PubMed ID: 23906602
[TBL] [Abstract][Full Text] [Related]
8. Discovery of O-GlcNAc-modified proteins in published large-scale proteome data.
Hahne H; Gholami AM; Kuster B
Mol Cell Proteomics; 2012 Oct; 11(10):843-50. PubMed ID: 22661428
[TBL] [Abstract][Full Text] [Related]
9. E. coli sabotages the in vivo production of O-linked β-N-acetylglucosamine-modified proteins.
Goodwin OY; Thomasson MS; Lin AJ; Sweeney MM; Macnaughtan MA
J Biotechnol; 2013 Dec; 168(4):315-23. PubMed ID: 24140293
[TBL] [Abstract][Full Text] [Related]
10. Human Alzheimer's disease synaptic O-GlcNAc site mapping and iTRAQ expression proteomics with ion trap mass spectrometry.
Skorobogatko YV; Deuso J; Adolf-Bryfogle J; Nowak MG; Gong Y; Lippa CF; Vosseller K
Amino Acids; 2011 Mar; 40(3):765-79. PubMed ID: 20563614
[TBL] [Abstract][Full Text] [Related]
11. Direct in-gel fluorescence detection and cellular imaging of O-GlcNAc-modified proteins.
Clark PM; Dweck JF; Mason DE; Hart CR; Buck SB; Peters EC; Agnew BJ; Hsieh-Wilson LC
J Am Chem Soc; 2008 Sep; 130(35):11576-7. PubMed ID: 18683930
[TBL] [Abstract][Full Text] [Related]
12. Identification of new O-GlcNAc modified proteins using a click-chemistry-based tagging.
Gurcel C; Vercoutter-Edouart AS; Fonbonne C; Mortuaire M; Salvador A; Michalski JC; Lemoine J
Anal Bioanal Chem; 2008 Apr; 390(8):2089-97. PubMed ID: 18369606
[TBL] [Abstract][Full Text] [Related]
13. Identification of O-GlcNAc sites on proteins.
Whelan SA; Hart GW
Methods Enzymol; 2006; 415():113-33. PubMed ID: 17116471
[TBL] [Abstract][Full Text] [Related]
14. Proteome wide purification and identification of O-GlcNAc-modified proteins using click chemistry and mass spectrometry.
Hahne H; Sobotzki N; Nyberg T; Helm D; Borodkin VS; van Aalten DM; Agnew B; Kuster B
J Proteome Res; 2013 Feb; 12(2):927-36. PubMed ID: 23301498
[TBL] [Abstract][Full Text] [Related]
15. O-linked N-acetylglucosamine proteomics of postsynaptic density preparations using lectin weak affinity chromatography and mass spectrometry.
Vosseller K; Trinidad JC; Chalkley RJ; Specht CG; Thalhammer A; Lynn AJ; Snedecor JO; Guan S; Medzihradszky KF; Maltby DA; Schoepfer R; Burlingame AL
Mol Cell Proteomics; 2006 May; 5(5):923-34. PubMed ID: 16452088
[TBL] [Abstract][Full Text] [Related]
16. Discovery of O-GlcNAc-6-phosphate modified proteins in large-scale phosphoproteomics data.
Hahne H; Kuster B
Mol Cell Proteomics; 2012 Oct; 11(10):1063-9. PubMed ID: 22826440
[TBL] [Abstract][Full Text] [Related]
17. Global identification of O-GlcNAc-modified proteins.
Nandi A; Sprung R; Barma DK; Zhao Y; Kim SC; Falck JR; Zhao Y
Anal Chem; 2006 Jan; 78(2):452-8. PubMed ID: 16408927
[TBL] [Abstract][Full Text] [Related]
18. Parallel identification of O-GlcNAc-modified proteins from cell lysates.
Tai HC; Khidekel N; Ficarro SB; Peters EC; Hsieh-Wilson LC
J Am Chem Soc; 2004 Sep; 126(34):10500-1. PubMed ID: 15327282
[TBL] [Abstract][Full Text] [Related]
19. Selective detection and site-analysis of O-GlcNAc-modified glycopeptides by beta-elimination and tandem electrospray mass spectrometry.
Greis KD; Hayes BK; Comer FI; Kirk M; Barnes S; Lowary TL; Hart GW
Anal Biochem; 1996 Feb; 234(1):38-49. PubMed ID: 8742080
[TBL] [Abstract][Full Text] [Related]
20. A novel strategy for global mapping of O-GlcNAc proteins and peptides using selective enzymatic deglycosylation, HILIC enrichment and mass spectrometry identification.
Shen B; Zhang W; Shi Z; Tian F; Deng Y; Sun C; Wang G; Qin W; Qian X
Talanta; 2017 Jul; 169():195-202. PubMed ID: 28411811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
